ANN ARBOR—Esperion Therapeutics Inc. has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a “positive opinion” for both its bempedoic acid and its benpedoic acid-ezetimibe tablets to treat high cholesterol and other risky conditions involving lipids in the bloodstream. Company officials said the committee “found there were no
FLINT - XLerateHealth, a Louisville, KY-based healthcare startup accelerator, has partnered with the University of Michigan to bring its Fast Forward Medical Innovation’s fastPACE biomedical entrepreneur program to XLH Flint. FFMI fastPACE is a four-week biomedical innovation and commercialization project-based course designed for life science innovators with an early stage project. More than 250 project
ANN ARBOR—Endocrine drug developer Millendo Therapeutics Inc. has promoted Thomas Hoover to the newly created position of chief commercial officer. Hoover joined Millendo in 2016 and has served as the company’s senior vice president of commercial strategy. “Tom has been instrumental in Millendo’s growth to date, and his promotion reflects his expanded responsibilities as well
FLINT—Diplomat Specialty Pharmacy, a provider of specialty pharmacy and infusion services, will be purchased by Eden Prairie, Minn.-based OptumRx, the pharmacy care business of Optum, a unit of the health insurance giant United Health Group, for $4 a share in cash and assumption of outstanding debt, valuing the company at about $300 million. Diplomat stock
ANN ARBOR–Kraig Biocraft Laboratories has completed the hatching of the second generation of its genetically engineered silkworms as it expands production at its breeding grounds and silk production centers in Quang Nam province, Vietnam. Company officials said that its Vietnamese subsidiary, Prodigy Textiles, would use the cocoons produced in this breeding cycle to begin its
ANN ARBOR—A new study from the University of Michigan asserts that targets to reduce phosphorous outputs from the Detroit area to control toxic blooms of cyanobacteria in Lake Erie are unrealistic if the phosphorous inputs from Lake Huron aren’t controlled as well. In an effort to control the cyanobacteria blooms and dead zones that plague
ANN ARBOR—The Ann Arbor-based genetic research software developer Genomenon Inc. announced the release of version 2.0 of its Mastermind software. The genomic search engine now includes the ability to search the entirety of the genomic literature by phenotypes (symptoms). This new functionality will further accelerate diagnosis of patients with genetic and rare diseases. Patients, particularly those with
CANTON - TrialAssure – a software company focused on developing clinical trial transparency tools – has released Anonymize DS, the all-new software-as-a-service application that uses automation to anonymize sponsor’s clinical trial data. “As one of the first groups to automate the anonymization of datasets, our developers heard first-hand feedback from industry users during the limited
DETROIT—Henry Ford e-Home Care has announced a significant reduction in hospital readmissions for patients receiving telehealth care via Henry Ford’s e-Home Care program. Achieving monthly readmission rates as low as 7 percent, Henry Ford e-Home Care has reduced its average hospital readmission rate for the first six months of 2019 by 45 percent compared with
ROYAL OAK—OncoCell MDx Inc., a startup incubated at Harvard University to develop sophisticated cancer diagnosis from a simple blood sample, has raised $22.2 million in a Preferred Series B funding round. The financing was led by San Francisco-based Savitr Capital LLC, with participation from existing investors. OncoCell began operations in 2013, and since then has
